Review: riluzole increases 12-month survival in amyotrophic lateral sclerosis...commentary on Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Review, latest version 26 Oct 1999. In: The Cochrane Library. Oxford: Update Software

Detalles Bibliográficos
Publicado en:ACP Journal Club Vol. 133; no. 2; pp. 54 - 55
Autor principal: Strong MJ
Formato: abstract commentary tables/charts Journal Article
Publicado: American College of Physicians 2000 Sep-Oct
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107009912&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107009912
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10568751
        1F4
      jtl: ACP Journal Club
      issn: 10568751
      maglogo: N
    pubinfo:
      dt: 2000 Sep-Oct
      vid: 133
      iid: 2
      pid: 1652
      pub: American College of Physicians
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        107009912
        107009912
        2001027806
        107009912
      ppf: 54
      ppct: 1
      formats:
      tig:
        atl: Review: riluzole increases 12-month survival in amyotrophic lateral sclerosis...commentary on Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Review, latest version 26 Oct 1999. In: The Cochrane Library. Oxford: Update Software
      aug:
        au: Strong MJ
        affil: University of Western Ontario, London, Ontario, Canada
      sug:
        subj:
          Amyotrophic Lateral Sclerosis Drug Therapy
          Excitatory Amino Acid Antagonists Therapeutic Use
          Clinical Trials
          Meta Analysis
          Treatment Outcomes
          Excitatory Amino Acid Antagonists Administration and Dosage
          Excitatory Amino Acid Antagonists Adverse Effects
          Administration, Oral
          Amyotrophic Lateral Sclerosis Mortality
          Muscle Strength
          Quality of Life
          Confidence Intervals
          Relative Risk
      pubtype: Academic Journal
      doctype:
        abstract
        commentary
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N